InVivo Therapeutics tumbles on up-listing delay

|About: InVivo Therapeutics Holding... (NVIV)|By:, SA News Editor

Shares of InVivo Therapeutics (NVIV.OB -17%) plummet after the company says plans to up-list to a national securities exchange have "been postponed indefinitely due to issues related to corporate governance."

SA contributor and Zacks analyst Jason Napodano says the company wouldn't disclose to him the nature of the issues but did say that it was a minor delay.